The Inducen™ INPT formula line is now available! Production and distribution are underway, with availability expected in ~4–6 weeks exclusively through licensed healthcare providers. Providers can purchase Inducen now —patients, let your doctor know it’s available.

PhagenCorp2025-05-12T16:08:17-06:00

Targeted Application of the Body’s Native Intelligence

Signal-calibrated oral solutions, designed to activate your body’s native phages in support of microbial balance and bioregulatory resilience.

What Is Induced Native Phage Therapy (INPT)?

Your body contains over 30,000 populations of naturally occurring bacteriophages—tiny, virus-like elements that are part of your microbiome from birth and work alongside the immune system to help maintain microbial equilibrium.

INPT, or Induced Native Phage Technology, is a proprietary method developed by PhagenCorp to selectively activate native phage populations using low-frequency electromagnetic signatures. These signals are imprinted into an oral solution containing trace nanoparticle elements, allowing targeted informational delivery to the body’s internal microbial regulation systems.

This is not a supplement. Not a pharmaceutical. And not a probiotic. It is a signal-based modality—entirely non-chemical, biologically gentle, and designed to interface with the body’s innate systems without disruption.

Introducing the Inducen™ Formula Line

The Inducen formulas are the first application of INPT, representing over a decade of research and refinement. Each formula contains dozens of precisely tuned electromagnetic signatures selected to encourage phage responses related to specific microbial terrains—ranging from the gastrointestinal tract and skin to the nervous system and vascular tissues.

To date, over 200,000 doses of Inducen have been administered in IRB-supported clinical research with no reported adverse effects—including in patients with complex sensitivities.

Each formula is non-toxic, non-allergenic, and supports the body without interfering with other therapies or beneficial flora. While these products are not intended to treat or cure disease, they offer a forward-thinking method for working with the body—not on it.

For Licensed Healthcare Providers

PhagenCorp partners exclusively with trained, licensed providers to ensure responsible and informed clinical application.
If you are a physician or healthcare practitioner interested in incorporating INPT into your practice, you may:

  • View Product Information – Explore the Inducen line
  • Apply for Access – Create a provider account
  • Complete Training – Take a short onboarding assessment
  • Place Your Order – Gain access to the practitioner-only store

For Patients and the Public

While Inducen is not available for direct purchase by consumers, you can explore each formula to better understand how it works and what it supports.

If you are experiencing chronic microbial imbalance or unresolved symptoms and would like to work with a provider trained in Induced Native Phage Technology, we invite you to:

  • Search for a Certified Provider Near You
  • Read Published Research and FAQs
  • Learn About Native Phages and Microbial Balance

Science, Safety, and Success

  • Over a decade of development

  • Peer-reviewed publication on clinical results

  • 200,000+ doses administered

  • No reported adverse events

  • Compatible with most treatment plans

  • Non-interfering and well tolerated—even by hypersensitive populations

News & Research Updates

Exclusive access to the latest information regarding PhagenCorp’s research trials, commercial opportunities, and biotechnology innovations.

By submitting my data I agree to be contacted

Keep up with us!

Sign up for our mailing list or follow us on social media to keep up with all of the latest happenings here at PhagenCorp!

We are committed to earning and maintaining our place at the forefront of medical innovation and excellence by providing constant, continued, and groundbreaking solutions for the abolition of disease.

PhagenCorp

Phage-Biotechnology & Precision Medicine Innovation

Go to Top